Literature DB >> 9552358

The role of cyclin E in the regulation of entry into S phase.

K Sauer1, C F Lehner.   

Abstract

Cyclin E is a crucial regulator of entry into S phase in higher eukaryotes and acts in association with the protein kinase cdk2. Cyclin E expression is transcriptionally controlled in mammalian cells resulting in a maximum just before entry into S phase. Premature expression of cyclin E advances entry into S phase, while lack of cyclin E prevents entry into S phase. Cyclin E/cdk2 activity is regulated at multiple levels (by transcription, phosphorylation and inhibitor proteins) and appears to be involved in triggering initiation of DNA replication and in regulating genes important for proliferation and progression through S phase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9552358     DOI: 10.1007/978-1-4615-1809-9_10

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  29 in total

1.  Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow.

Authors:  Mo A Dao; Jan A Nolta
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

2.  The chromatin-remodeling protein Osa interacts with CyclinE in Drosophila eye imaginal discs.

Authors:  Jawaid Baig; Francoise Chanut; Thomas B Kornberg; Ansgar Klebes
Journal:  Genetics       Date:  2009-12-14       Impact factor: 4.562

3.  Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance.

Authors:  N Kato; J Watanabe; T Jobo; Y Nishimura; T Fujisawa; Y Kamata; H Kuramoto
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-08       Impact factor: 4.553

4.  MicroRNA miR-16-1 regulates CCNE1 (cyclin E1) gene expression in human cervical cancer cells.

Authors:  Ma Isabel Zubillaga-Guerrero; Luz Del Carmen Alarcón-Romero; Berenice Illades-Aguiar; Eugenia Flores-Alfaro; Víctor Hugo Bermúdez-Morales; Jessica Deas; Oscar Peralta-Zaragoza
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Targeting low molecular weight cyclin E (LMW-E) in breast cancer.

Authors:  Angela Nanos-Webb; Natalie A Jabbour; Asha S Multani; Hannah Wingate; Nassima Oumata; Hervé Galons; Benoît Joseph; Laurent Meijer; Kelly K Hunt; Khandan Keyomarsi
Journal:  Breast Cancer Res Treat       Date:  2011-06-22       Impact factor: 4.872

6.  Cell cycle events during the development of the silk glands in the mulberry silkworm Bombyx mori.

Authors:  Sangeeta Dhawan; K P Gopinathan
Journal:  Dev Genes Evol       Date:  2003-07-17       Impact factor: 0.900

7.  Prognostic value of cyclin E expression in breast cancer: a meta-analysis.

Authors:  Sheng Gao; Jing-Jing Ma; Cheng Lu
Journal:  Tumour Biol       Date:  2013-06-18

8.  sSgo1, a major splice variant of Sgo1, functions in centriole cohesion where it is regulated by Plk1.

Authors:  Xiaoxing Wang; Yali Yang; Qing Duan; Ning Jiang; Ying Huang; Zbigniew Darzynkiewicz; Wei Dai
Journal:  Dev Cell       Date:  2008-03       Impact factor: 12.270

9.  Cyclin-dependent kinase 2/cyclin E complex is involved in p120 catenin (p120ctn)-dependent cell growth control: a new role for p120ctn in cancer.

Authors:  Nicolas T Chartier; Christiane I Oddou; Michèle G Lainé; Benjamin Ducarouge; Christiane A Marie; Marc R Block; Muriel R Jacquier-Sarlin
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

10.  siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model.

Authors:  Yulong Liang; Hong Gao; Shiaw-Yih Lin; John A Goss; Francis C Brunicardi; Kaiyi Li
Journal:  PLoS One       Date:  2010-09-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.